Evolvence India Life Sciences Fund (EILSF) has committed to invest upto Rs. 35 crore in Sutures India, a Bangalore-based company specializing in the manufacture of surgical consumables.
Sutures India manufactures a range of wound closure products such as natural and synthetic absorbable and non-absorbable sutures, surgical needles, staples, tapes, hernia meshes, and disposable surgical gloves. For more information on Sutures India, visit http://www.suturesin.com
Other companies that the $150 million EILSF has invested into include Hyderabad-based pharmaceuticals firm Gland Pharma, Bangalore-based oncology hospital firm HealthCare Global Enterprises and Chennai-based pharmaceuticals company Anjan Drugs.